InsidersTradesSigma
Track the RedHill Biopharma Ltd. stock price and the full directors' dealings record of the company, a listed issuer based in United States. Shares are quoted on the US market, under the oversight of SEC (Form 4). Market capitalisation: €3.7m. The latest transaction was disclosed on 13 July 2026 (Cession). Among the most active insiders: Raday Gilead. All data is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
2 of 2 declarations
RedHill Biopharma Ltd. 是一家生物制药公司，专注于开发胃肠道疾病的治疗方法。该公司在纳斯达克上市，股票代码为 RDHL。